当前位置:首页 - 行情中心 - 高新发展(000628) - 财务分析 - 利润表

高新发展

(000628)

  

流通市值:96.88亿  总市值:177.69亿
流通股本:1.92亿   总股本:3.52亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入1,156,524,789.218,008,118,403.354,505,883,732.162,832,256,597.93
营业收入1,156,524,789.218,008,118,403.354,505,883,732.162,832,256,597.93
二、营业总成本1,119,469,776.87,762,642,932.414,279,614,113.552,668,451,073.6
营业成本1,035,240,272.517,377,218,616.614,001,779,774.662,492,019,090.21
税金及附加4,566,102.3519,061,527.4114,621,923.679,015,701.15
销售费用8,783,121.4271,896,451.464,429,566.6245,115,522.75
管理费用41,300,369.99179,565,094.89119,295,729.0276,838,173.54
研发费用13,685,986.2840,031,145.4923,815,372.4412,829,528.9
财务费用15,893,924.2574,870,096.6155,671,747.1432,633,057.05
其中:利息费用18,302,556.9188,836,812.3158,742,574.6636,625,778.6
其中:利息收入2,600,961.8515,784,672.1514,217,789.4210,557,268.38
加:公允价值变动收益399,088.965,039,364.013,887,236.463,993,979.15
加:投资收益1,723,698.1255,758,509.58234,311,961.08-1,881,164.07
资产处置收益29,610.0622,238.644,303.5819,264.76
资产减值损失(新)-3,794,444.49-5,081,267.78-1,310,735.66-618,486.39
信用减值损失(新)19,182,988.8744,251,933.91-58,128,116.16-26,314,462.27
其他收益1,844,282.398,003,391.811,264,969.531,029,261.77
营业利润平衡项目0000
四、营业利润56,440,236.3553,469,641.11406,299,237.44140,033,917.28
加:营业外收入78,568.171,802,182.92896,284.88702,207.22
减:营业外支出112.38177,410.54169,512.78111,803.55
利润总额平衡项目0000
五、利润总额56,518,692.09555,094,413.49407,026,009.54140,624,320.95
减:所得税费用26,804,433.33223,736,427.73163,490,885.1851,222,675.6
六、净利润29,714,258.76331,357,985.76243,535,124.3689,401,645.35
持续经营净利润29,714,258.76331,357,985.76243,535,124.3689,401,645.35
归属于母公司股东的净利润34,497,946.45365,937,536.58253,867,139.3993,313,157.5
少数股东损益-4,783,687.69-34,579,550.82-10,332,015.03-3,911,512.15
(一)基本每股收益0.11.040.720.27
(二)稀释每股收益0.11.040.720.27
九、综合收益总额29,714,258.76331,357,985.76243,535,124.3689,401,645.35
归属于母公司股东的综合收益总额34,497,946.45365,937,536.58253,867,139.3993,313,157.5
归属于少数股东的综合收益总额-4,783,687.69-34,579,550.82-10,332,015.03-3,911,512.15
公告日期2024-04-262024-03-262023-10-282023-08-30
审计意见(境内)标准无保留意见
TOP↑